Aldeyra Therapeutics Announces Second-Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Aldeyra Therapeutics Announces Second-Quarter 2020 Financial Results and Provides Corporate Update

Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 9c

August 6, 2020 7:25 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34).

We continue to make important progress in advancing a number of clinical-stage programs focused on the development of reproxalap and ADX-629, our first-in-class reactive aldehyde species (RASP)... More